About us

ANTABIO is a France-based private biopharmaceutical company dedicated to the discovery and development of game-changing treatments of life-threatening and drug-resistant bacterial infections. ANTABIO uses proprietary in vitro technologies and extensive bacterial disease know-how to develop the next generation of antibacterial drugs targeting severe and difficult-to-treat infections caused by multi-drug resistant gram-negative pathogens.


Nosocomial infections